Fertility tests assist individuals to check their fertility status. Fertililty tests help detect problems that may affect one's ability to conceive naturally. These tests help to determine the optimal time for conception and offer guidance on medical intervention if needed. These tests are especially important for couples who are trying to conceive but unable to achieve pregnancy for over 12 months despite regular unprotected intercourse. The rising cases of infertility due to increasing age, lifestyle changes, environmental pollution and stress levels have bolstered the demand for effective and reliable fertility tests.
Market key trends:
The increased prevalence of infertility has been a key growth driver for the fertility test market. According to the WHO, infertility affects about 48.5 million couples worldwide and around 60-80 million people in India are estimated to be infertile. Rising infertility rates can be attributed to changing lifestyle, late parenthood, obesity, stress levels and increased pollution levels over the years. Advanced technologies for fertility testing allow early detection and management of infertility which is encouraging more people to opt for fertility tests. Self-testing kits also enable discretion and convenience which is boosting their demand. Growing awareness about fertility testing and availability of various testing options are some of the major factors expected to provide opportunities for market growth over the forecast period.
Segment Analysis
The global fertility test market is dominated by the at-home use segment. This segment held more than 60% share of the overall market in 2023 led by growing preference for self-administered testing. Home use tests are convenient, inexpensive and offer privacy. The accuracy of leading brands has also ensured rising adoption of these tests in recent years.
Key Takeaways
The Global Fertility Test Market Demand is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030.
Regional analysis: North America leads the fertility test market and is expected to maintain dominance over the forecast period. High awareness levels, easy availability of advanced products and growing infertility rates in the US and Canada provide an impetus to regional growth. Meanwhile, Asia Pacific is anticipated to exhibit the fastest growth rate through 2030 on account of large population base, improving access to diagnostic services and rising medical tourism in countries such as India and China.
Key players: Key players operating in the fertility test market are AstraZeneca, Novartis AG, GSP plc, Merck & Co., Inc., Verona Pharma plc, Regeneron Pharmaceuticals Inc., and Boehringer Ingelheim International GmbH. AstraZeneca and Novartis AG currently hold the leading market positions in global market owing to their robust portfolio of fertility products and global distribution network. Other mid-sized companies are focusing on regional expansions and increasing production to cater to the unmet needs. The fertility test market provides lucrative opportunities for new entrants as well. Competition is likely to further intensify with the entry of new players in the coming years.
Explore more information on this topic, Please visit -
https://www.insightprobing.com/fertility-test-market-share-and-demand-analysis/
Explore more trending article related this topic -
https://www.ukwebwire.com/vertical-farming-market-future-prospects-and-forecast-analysis/
Comments
0 comment